SCOPUS 정보 검색 플랫폼

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 6, 2011, Pages 304-306

Hepatitis: PEG-IFN for the treatment of hepatitis D

(2) Ciancio, Alessia a Rizzetto, Mario a

a UNIVERSITY OF TURIN (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; HEPATITIS B SURFACE ANTIGEN; PEGINTERFERON ALPHA2A; VIRUS RNA;

ARTICLE; DELTA AGENT HEPATITIS; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MONOTHERAPY; PRIORITY JOURNAL; RNA SYNTHESIS; SIDE EFFECT; THROMBOCYTE COUNT; TREATMENT OUTCOME; VIRAL CLEARANCE;

ADENINE; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS B, CHRONIC; HEPATITIS D; HUMANS; INTERFERON ALFA-2A; PHOSPHONIC ACIDS; POLYETHYLENE GLYCOLS; TREATMENT OUTCOME;

EID: 79958098621 PISSN: 17595045 EISSN: 17595053 Source Type: Journal
DOI: 10.1038/nrgastro.2011.85 Document Type: Article

Times cited : (10)

References (10)

1
- 64749114179
- Hepatitis D: Thirty years after
- Rizzetto, M. Hepatitis D: thirty years after. J. Hepatol. 50, 1043-1050 (2009).
- (2009) J. Hepatol. , vol.50 , pp. 1043-1050
- Rizzetto, M.¹

2
- 40149083430
- Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon
- DOI 10.1111/j.1365-2893.2007.00936.x
- Yurdaydin, C., et al. Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon. J. Viral Hepat. 15, 314-321 (2008). (Pubitemid 351326903)
- (2008) Journal of Viral Hepatitis , vol.15 , Issue.4 , pp. 314-321
- Yurdaydin, C.¹ Bozkaya, H.² Onder, F.O.³ Senturk, H.⁴ Karaaslan, H.⁵ Akdogan, M.⁶ Cetinkaya, H.⁷ Erden, E.⁸ Erkan-Esin, O.⁹ Yalcin, K.¹⁰ Bozdayi, A.M.¹¹ Schinazi, R.F.¹² Gerin, J.L.¹³ Uzunalimoglu, O.¹⁴ Ozden, A.¹⁵

3
- 79958161668
- (eds Rodes J. & Arroyo V.) 242-252 (Ediciones Doyma, 1992)
- Rizzetto M. & Rosina F. in Therapy in Liver Diseases (eds Rodes J. & Arroyo V.) 242-252 (Ediciones Doyma, 1992).
- Therapy in Liver Diseases
- Rizzetto, M.¹ Rosina, F.²

4
- 33746791063
- Treatment of chronic hepatitis delta with pegylated interferon-α2b
- DOI 10.1111/j.1478-3231.2006.01279.x
- Erhardt, A., et al. Treatment of chronic hepatitis delta with pegylated interferon-alpha2b. Liver Int. 26, 805-810 (2006). (Pubitemid 44172032)
- (2006) Liver International , vol.26 , Issue.7 , pp. 805-810
- Erhardt, A.¹ Gerlich, W.² Starke, C.³ Wend, U.⁴ Donner, A.⁵ Sagir, A.⁶ Heintges, T.⁷ Haussinger, D.⁸

5
- 33748943782
- Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
- DOI 10.1002/hep.21325
- Castelnau, C., et al. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 44, 728-735 (2006). (Pubitemid 44433730)
- (2006) Hepatology , vol.44 , Issue.3 , pp. 728-735
- Castelnau, C.¹ Le Gal, F.² Ripault, M.-P.³ Gordien, E.⁴ Martinot-Peignoux, M.⁵ Boyer, N.⁶ Pham, B.-N.⁷ Maylin, S.⁸ Bedossa, P.⁹ Deny, P.¹⁰ Marcellin, P.¹¹ Gault, E.¹²

6
- 33748947285
- Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta
- DOI 10.1002/hep.21296
- Niro, G. A., et al. Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 44, 713-720 (2006). (Pubitemid 44433728)
- (2006) Hepatology , vol.44 , Issue.3 , pp. 713-720
- Niro, G.A.¹ Ciancio, A.² Gaeta, G.B.³ Smedile, A.⁴ Matrone, A.⁵ Olivero, A.⁶ Stanzione, M.⁷ David, E.⁸ Brancaccio, G.⁹ Fontana, R.¹⁰ Perri, F.¹¹ Andriulli, A.¹² Rizzetto, M.¹³

7
- 79251490096
- Peginterferon plus adefovir versus either drug alone for hepatitis delta
- HIDIT Study Group
- Wedemeyer, H., et al. HIDIT Study Group. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N. Engl. J. Med. 364, 322-331 (2011).
- (2011) N. Engl. J. Med. , vol.364 , pp. 322-331
- Wedemeyer, H.¹

8
- 0023089742
- Titration of the infectivity of hepatitis D virus in chimpanzees
- Ponzetto, A., et al. Titration of the infectivity of hepatitis D virus in chimpanzees. J. Infect. Dis. 155, 72-78 (1987). (Pubitemid 17225085)
- (1987) Journal of Infectious Diseases , vol.155 , Issue.1 , pp. 72-78
- Ponzetto, A.¹ Hoyer, B.H.² Popper, H.³

9
- 2942568157
- Long-term benefit of interferon α therapy of chronic hepatitis D: Regression of advanced hepatic fibrosis
- DOI 10.1053/j.gastro.2004.03.017
- Farci, P., et al. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology 126, 1740-1749 (2004). (Pubitemid 38736339)
- (2004) Gastroenterology , vol.126 , Issue.7 , pp. 1740-1749
- Farci, P.¹ Roskams, T.² Chessa, L.³ Peddis, G.⁴ Mazzoleni, A.P.⁵ Scioscia, R.⁶ Serra, G.⁷ Lai, M.E.⁸ Loy, M.⁹ Caruso, L.¹⁰ Desmet, V.¹¹ Purcell, R.H.¹² Balestrieri, A.¹³

10
- 79958094532
- Preclinical studies on myrcludex b, a novel entry inhibitor for hepatitis B and hepatitis delta virus (HDV) infections [abstract 10]
- Urban, S., et al. Preclinical studies on myrcludex b, a novel entry inhibitor for hepatitis B and hepatitis delta virus (HDV) infections [abstract 10]. J. Hepatol. 52 (Suppl.), S5 (2010).
- (2010) J. Hepatol. , vol.52 , Issue.SUPPL.
- Urban, S.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.